NL-OMON37040已完成不适用
A Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX872-B in Healthy Male and Female Subjects - CCX872-B SAD/MAD study
Chemocentryx0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •healthy male or female
- •18 - 65 years inclusive
- •BMI 18 - 35 kg/m2 inclusive
- •non-smoker
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS.
- •Participation in another drug study within 60 days prior to randomization.
- •Any donation of blood(products) or significant blood loss within 56 dagen voor de keuring.
研究者
相似试验
已完成
1 期
Phase I study to assess the safety and tolerability of inhaled interferon-beta (IFN-beta1a) in controlled asthmatic male and female subjectsAsthmaISRCTN83107787Synairgen Research Limited (UK)40
已完成
不适用
Clinical trial to evaluate the safety and tolerability of CCX507-B in healthy subjectsISRCTN79241600ChemoCentryx, Inc. (USA)30
已完成
2 期
A Clinical trial to study the effect of an anti-diarrheal drug Crofelemer in patients with infectious diarrheaCTRI/2009/091/000361Glenmark Pharmaceuticals Ltd.80
招募中
2 期
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Exploratory Study of the Safety and Efficacy of JNJ-39758979 in the Treatment of Adults with Persistent AsthmaCTRI/2010/091/001010Johnson & Johnson Pharmaceutical Research and Development100
进行中（未招募）
1 期
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Three-Arm, Multi-Site Study to Evaluate the Clinical Equivalence of Diclofenac Sodium Topical Gel 1% (Hi-Tech Pharmacal Co., Inc.) with Voltaren® Gel (Diclofenac Sodium Topical Gel) 1%(Novartis) in Patients with Osteoarthritis of the Knee.osteoarthritis of the kneeEUCTR2014-002279-27-LVHi-Tech Pharmacal Co., Inc.750